Fibrocor Therapeutics Enhances Clinical Strategy with Nephrology Experts for Alport Syndrome Fibrocor Therapeutics has appointed four leading nephrology experts to its Clinical Advisory Board, focusing on advancing treatments for Alport Syndrome.

Fibrocor Therapeutics Enhances Clinical Strategy with Nephrology Experts for Alport Syndrome #Canada #Toronto #Alport_Syndrome #Fibrocor #Nephrology_Experts